Company Search:
Advanced Search
Sponsored Links
Novo Nordisk As Company Snapshot
Novo Nordisk As operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other pharmaceutical manufacturers in Europe: UCB Sa of Belgium (2017 sales of 4.53 billion Euro [US$5.22 billion] of which 100% was Biopharmacy), Merck KGaA of Germany (15.33 billion Euro [US$17.68 billion] of which 46% was Healthcare), and AstraZeneca PLC which is based in the United Kingdom (£17.25 billion [US$22.12 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2017, sales at Novo Nordisk As were 111.70 billion Danish Kroner (US$17.26 billion). This is a decrease of 0.1% versus 2016, when the company's sales were 111.78 billion Danish Kroner. Contributing to the drop in overall sales was the 17.6% decline in Biopharmaceuticals, from 22.83 billion Danish Kroner to 18.82 billion Danish Kroner. . However, these declines were partially offset by the increase in sales of Diabetes Care (up 4.4% to 92.88 billion Danish Kroner) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novo Nordisk As
  Stock Performance Chart for Novo Nordisk As
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2019): 314.35
(Figures in Danish Kroner)
1 Week 0.5%   13 Weeks 1.4%  
4 Weeks 15.0%   52 Weeks -6.6%  
Novo Nordisk As Key Data:
  Ticker: NOVOB Country: Denmark
  Exchanges: CPH OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 111,696,000,000
(Year Ending Jan 2018).
Employees: 42,076
  Currency: Danish Kroner Market Cap: 752,553,900,000
  Fiscal Yr Ends: December Shares Outstanding: 2,394,000,000
  Share Type: B Stamaktie Closely Held Shares: 659,840,096
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.